Steroid production and metabolism by early conceptuses are very important for the establishment and maintenance of pregnancy in horses. Our earlier work suggested the possible formation of 5alpha-reduced steroids in equine conceptuses. We have now demonstrated the formation of 5alpha-reduced metabolites of androstenedione, testosterone, and progesterone by the embryo and its membranes. A total of 44 conceptuses were collected from 26 mares between 20 and 31 days of pregnancy. Tissues from the embryo proper and from the separated components of the conceptus (bilaminar and trilaminar trophoblast, allantois) were incubated with tritium-labeled substrates. 5Alpha-reduced metabolites (5alpha-dihydro-and 3beta,5alpha-tetrahydro-steroids) as radiolabeled products were identified from a series of chromatographic steps using four solvent systems for high-performance liquid chromatography. Use of a 5alpha-reductase inhibitor confirmed the metabolites were indeed 5alpha-reduced steroids. For the embryo, the only products from androstenedione were 5alpha-dihydroandrostenedione and 3be-ta,5alpha-tetrahydroandrostenedione, with no evidence of more polar metabolites; there was some 3beta,5alpha-tetrahydrotestosterone but no 5alpha-dihydrotestosterone from testosterone, and formation of androstenedione was followed by the production of 5alpha-dihydroandrostenedione and 3beta,5alpha-tetrahydroandrostenedione. The major 5alpha-reduced product from progesterone was 3beta,5alpha-tetrahydroprogesterone, with lesser amounts of 5alpha-dihydroprogesterone. For the membranes, reductions to tetrahydro, 5alpha-reduced steroids were prominent in most instances, but also present were considerable amounts of products more polar than the substrates. The wellrecognized activity of some 5alpha-reduced steroids-for example, 5alpha-dihydrotestosterone in male sexual differentiationprovokes interest in their even earlier appearance, as seen in this study, and suggests a possible role for them in early embryonic development in horses and, more generally, in other species. 5alpha-reduced steroids, androstenedione, conceptus membranes, early equine embryo, HPLC, progesterone, radiolabeled substrates, steroid metabolism, testosterone
INTRODUCTION
Steroid production and metabolism in the conceptus are considered to be very important for the establishment and maintenance of pregnancy in equids. In an investigation on aromatase activity in early equine conceptuses, incubation of tissues with radiolabeled androstenedione ([ 3 H]-A 4 ) provided evidence suggestive of 5-reductase activity [1] . What relevance 5-reduction of steroids might have in the development of the early mammalian embryo has not yet been determined, but it is well known that 5a-dihydrotestosterone (5a-DHT) formed from testosterone (T 4 ) has a crucial role in human fetal sexual development [2] . In the adult male DHT is also a major factor in the cell proliferation that leads to benign prostatic hyperplasia [3] and prostate cancer [4] . Likewise, progesterone (P 4 ) is converted by 5a-reductase to 5a-dihydroprogesterone (5a-DHP), which stimulates cell proliferation in breast tissue, also with relevance to cancer [5] . Further metabolism by local activity of 3-hydroxysteroid-oxidoreductase has been shown in some tissues to form a tetrahydro metabolite, 3a,5a-tetrahydroprogesterone (3a,5a-THP; allopregnanolone), which could also have a regulatory role in an autocrine/paracrine manner. Such is the case for the anterior pituitary and hypothalamus in gonadotropin regulation in the rat [6] . With particular relevance to our studies of early equine pregnancy, it has been demonstrated recently that 5a-DHP is an endogenous, biopotent P 4 receptor agonist in the pregnant mare [7] . Based on this knowledge it was decided to establish the existence of 5a-reductase activity in the equine conceptus and to examine the nature of the metabolites formed, using steroids known to be present in yolk sac fluid that might be substrates for the enzyme in early pregnancy.
Metabolism of steroid hormones by the early mammalian embryo has received less attention than its potential contribution to the early stages of embryo development might warrant. Reduction products of P 4 metabolism in early pregnancy were first recorded in 1966 in a classical study by Huff and Eik-Nes [8] , in which rabbit blastocysts not only metabolized P 4 but synthesized cholesterol and pregnenolone (P 5 ) from acetate. An even earlier onset of P 4 reduction was demonstrated with hamsters, where 5a-DHP and 3b,5a-THP were formed at the morula stage [9] . That steroid metabolism in more general terms may be an inherent property of undifferentiated embryos and have biological significance was demonstrated in recent studies with mouse embryonic stem cells (mES cells) [10] . In embryoid bodies formed from several independent cell lines of mES cells, key enzymes necessary for androgen formation were expressed and actual biosynthesis of T 4 occurred. The expressions of the androgen receptor (AR) mRNA and protein were also revealed. Moreover, it was shown that T 4 promoted formation of beating cardiomyocytes in these embryoid bodies, thereby demonstrating that the AR is functional-suggesting a local mechanism for androgen-supported cardiomyocyte differentiation. This activity is remarkably earlier than can be associated with the role of androgens in sexual development at the fetal stage in the male.
Insofar as 5a-reduced metabolites can have regulatory roles as autocrine/paracrine agents in normal tissues, the objectives of the present study were to confirm the presence, and to investigate the extent, of 5a-reductase activity toward C 21 and C 19 neutral steroids by equine embryos and their extraembryonic membranes. Horses offer the opportunity to study steroid metabolism at a relatively early stage in development and, where size allows, the separate examination of the embryo proper and its various associated membranes. The studies were conducted in parallel with a separate investigation of early pregnancy failure in the mare in the same herd [11] , with the aim of understanding the significance of steroid hormones in embryonic growth and development in the horse and, by implication, other mammalian species.
MATERIALS AND METHODS

Chemicals and Reagents
Nonradioactive steroids were purchased from Steraloids Inc. (Newport, RI). The radioactive steroids (NEN) obtained from Perkin-Elmer (Shelton, CT) were [1,2,6,7- 3 H]-androst-4-ene-3,17-dione (101 Ci/mmol), [1,2,6, 
Collection of Conceptuses
Standardbred and Thoroughbred mares (n ¼ 26) from the research herd at the University of Guelph were used to recover conceptuses (n ¼ 44) on Days 20-31.5 of gestation (ovulation ¼ Day 0) during 40 pregnancies, as shown in Table 1 . A total of 14 of the mares were used during one pregnancy, 11 during two pregnancies, and 1 during four pregnancies. Of the 40 pregnancies, 32 were singleton, 7 were twin, and 1 was triplet. A total of 25 of the 40 pregnancies were established specifically for this study; the remaining 15 (two at Day 20, three at Day 21, seven at Day 22, and three at Day 23) were control pregnancies from the concurrent pregnancy failure study [11] , for which the mares had been injected i.m. with 1 ml of physiological saline 2-4 days before conceptus collection. Collections were made under conditions approved by the University Animal Care Committee (Animal Utilization Protocol no. 1428). The timing of ovulation was monitored by transrectal ultrasonography either daily or occasionally at intervals of 2 or 3 days; ovulation was deemed to have occurred midway between examinations showing an intact follicle and a corpus luteum. Thus, ages of conceptuses were subject to an error of 60.5 (n ¼ 35 pregnancies), 61 (n ¼ 3), or 61.5 (n ¼ 2) days. All 44 conceptuses used in the study were adjudged normal based on patterns of growth in utero determined by ultrasonography from the time of pregnancy diagnosis at Day 11 until the day of collection and then, during dissection, by morphological assessments of vascularity, heartbeat, and circulation in embryonic blood vessels.
Conceptuses were collected from mares by transcervical uterine lavage with Dulbecco PBS, pH 7.4, using a technique previously described [11] . Mares were sedated with xylazine hydrochloride (Rompun; BAY-VET, Etobicoke, ON), administered i.v., usually 0.3 mg/kg body weight. The flush fluid (1000 ml, repeated as necessary) was infused by gravity flow and drained into a beaker to recover the conceptus.
Tissue Preparation and Incubation
Under a dissecting microscope, the embryo in PBS was dissected free of its extraembryonic membranes using ophthalmic scissors and forceps. The weights ranged between about 5 and 25 mg, reflecting age at recovery. After separation, the embryo was washed in TCM 199, finely minced with scissors (;1-mm 3 pieces), and incubated, in duplicate where tissue amounts permitted, in small flasks containing 2 ml of TCM 199 to which one of the [ 3 H]-labeled substrates (1 3 10 6 cpm) had been added for incubation using a shaking water bath at 378C under 5% CO 2 in air for 2 h. When the 5a-reductase inhibitor (4-MA) was used, a preincubation of 15 min with the inhibitor was followed by addition of the radiolabeled substrate for the usual 2-h incubation period.
The trophoblast was divided into bilaminar (trophectoderm and endoderm) and trilaminar (trophectoderm, mesoderm, and endoderm) components by dissection, and these were incubated separately (10-20 and 35-70 mg of tissue, respectively). Allantoic tissues (10-20 mg) were also incubated in some cases. All tissues were incubated in duplicate with radiolabeled substrates as described for the embryo.
Recovery of Steroids
After incubation and removal of the media from the small flasks, the tissues were rinsed in each case with 200 ll of fresh medium, which was then added to the collected medium. Steroids were recovered from the medium by solid-phase extraction (SPE) as described previously [12] . Briefly, the incubation medium was diluted with water to a volume of 5 ml for SPE (Waters C18 Sep-Pak column; Waters Limited, Mississauga, ON). Unconjugated and conjugated steroids were eluted from the primed columns with 5 ml of diethyl ether and 5 ml of methanol, successively. The ether eluates were evaporated under nitrogen at ,458C, and a separation of phenolic from neutral steroids was done by partitioning the dried ether residue between 5 ml of toluene and 5 ml of N NaOH, as described previously [1] . The toluene fraction was washed 2 3 1 ml H 2 O, was evaporated as above, and the residue was used for chromatography. The amounts of radioactive material recovered from each incubation, each SPE fraction, and each partitioning fraction were determined by liquid scintillation counting of an aliquot in 4 ml of Ecolite scintillation cocktail (MP Biochemicals, Solon, OH).
Chromatographic Separation
Profiles of neutral steroids from SPE were generated by chromatography on a Waters HPLC System using a Nova-Pak C18 column with ultraviolet absorbance monitored at 210 and 254 nm. Four solvent systems were used: 1) a binary solvent gradient (Waters no. 8) of acetonitrile:water (28:72 to 90:10, during 40 min) at a flow rate of 700 ll/min; 2) a binary gradient (Waters no. 8) of acetonitrile:water (40:60 to 60:40, during 40 min) at 700 ll/min; 3) a ternary solvent gradient (Waters no. 7) of acetonitrile:water:methanol (4.2:49:46.8 to 20:10:70, during 30 min) at 600 ll/min; and 4) an isocratic solvent system of 45% acetonitrile in water during 40 min at 700 ll/min. Fraction collections were set for 1-min intervals for all systems, with an aliquot (usually one tenth) from each fraction taken for liquid scintillation counting. Identification of a radiolabeled metabolite was based on ''coelution'' with an authentic reference steroid run as an internal standard. Definitive identification was assigned when coelution with an authentic reference steroid was seen after three consecutive solvent systems had been used in a progressive manner; thus, at each step the material of interest in the preceding HPLC was run with reference standards in the subsequent chromatograph. An intrinsic time lag in fractional collection of the radiolabeled material resulted in a slight delay in recording the retention time from that observed for the absorbance of the associated reference standard. RAESIDE ET AL.
Statistical Analysis
Results for the extent of steroid conjugation and aromatization are expressed as means 6 SDs. Data were analyzed by Student t-test; differences were considered significant when P , 0.05. Quantification for comparison of the relative amounts of metabolites formed was attempted by measurement of areas under the peaks; however, this could be done with confidence only after several chromatographic steps with inherent losses, especially for P 4 . As a consequence, the comparisons remain largely qualitative and do not permit detection of changes during the period of development covered in this study.
RESULTS
Evidence for the Formation of 5a-Reduced Metabolites
Differences in the metabolism of physiologically relevant C 19 (A 4 and T 4 ) and C 21 (P 4 ) steroids by the embryo proper and its associated membranes were revealed in the HPLC profiles of the free neutral steroids in media extracts (Fig. 1) . In all instances, the evidence for formation of 5a-reduced metabolites as a major feature was provided by the presence of radioactive products that were less polar than each of the respective substrates. The most remarkable profiles were obtained with A 4 and T 4 as substrates for the embryo proper; here, an almost exclusive appearance of nonpolar peaks was noted (Fig. 1A , at 29 and 32 min, and Fig. 1E , at 26, 29, and 32 min). On the other hand, some metabolism to much more polar products accompanied the ''5a-reduced metabolites'' formed by the trophoblast (Fig. 1, C, D , and H). With P 4 as substrate the HPLC profiles for the embryo were not as markedly different from those of its membranes (Fig. 1, I-L) . All showed the possible presence of 5a-reduced products; however, radioactivity in the form of more polar metabolites was noted in greater amounts for incubations with the conceptus membranes.
Identification of 5a-Reduced Metabolites of Androstenedione
The primary aim of the investigation was the identification of steroids suspected of being 5a-reduced metabolites: metabolites (DHA [5a-dihydroandrostenedione]; 3a/b,5a-THA; DHT; 3a/b,5a-THT; 5a-DHP; and 3a/b,5a-THP) formed by the embryo. This was accomplished by further chromatography with reference standards in at least two additional solvent systems. After incubation of A 4 each of the two nonpolar metabolites formed by the embryo (Fig. 1A , 29-and 32-min fractions) was examined in turn. It was shown that the radioactive material at 29 min was aligned with the reference standard of 3b,5a-THA in solvent system 2 ( Fig. 2A,  13 min) . The identification of material at 13 min was further established by a third HPLC, using solvent system 3 containing methanol (Fig. 2B) . This revealed the presence of a hydroxyl group, as seen for the reference standard of 3b,5a-THA, by an altered retention time relative to those of the reference standards of A 4 and DHA. Again, the retention time of the radioactive metabolite (Fig. 2B, 23 min) matched that observed for the 3b,5a-THA standard. Similarly, the identity of radioactivity in the peak at 32 min (Fig. 1A ) was shown to be DHA (Fig. 2, C and D) . In this case the absence of a hydroxyl group was inferred from the HPLC profile in which no change in retention time of the metabolite was noted in 
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relation to A 4 and DHA standards in the methanolic solvent system. As expected, retention times of both 3a,5a-THA and 3b,5a-THA standards were affected. All of these findings were obtained repeatedly with other embryos (data not shown). Thus, it was established that DHA and 3b,5a-THA (epiandrosterone) were the major metabolites from incubations of the embryo proper with A 4 .
Identification of 5a-Reduced Metabolites of Testosterone
Three nonpolar radioactive peaks from T 4 were observed clearly for the embryo, but more variably so for the membranes (Fig. 1, E-H) . Each of the products for the embryo only was examined by further chromatography where radioactivity in the first peak (26 min; Fig.1E ) was found to be radiolabeled A 4 (data not shown). The second peak (29 min; Fig. 1E ) was identified as 3b,5a-THA by its behavior in two sequential HPLC systems (Fig. 3, A and B) , rather than DHT, as had been anticipated initially. The third peak (32 min; Fig. 1E ) was revealed as DHA (Fig. 3C ) and confirmed when it remained with the DHA reference standard in the methanol system (Fig.  3D) . Because 3b,5a-THA had been identified as a metabolite of T 4 , formed secondarily from A 4 , we sought to find whether lesser amounts of 3b,5a-THT (3b,17b-androstanediol or 3b,5a-tetrahydrotestosterone) might also be present. Trace amounts of radioactivity in T 4 incubations (fractions 24 and 25 min; Fig. 1E ) for several embryos (n ¼ 5) were pooled. The HPLC in a 40% acetonitrile isocratic system, followed by the system with methanol, demonstrated the presence of 3b,5a-THT (data not shown). Similar results were obtained for pooled replicates for each of the conceptus membranes (data not shown). Thus, DHA and 3b,5a-THA were identified as the principal 5a-reduced products of T 4 as well as 3b,5a-THT.
Identification of 5a-Reduced Metabolites of Progesterone
Nonpolar radioactivity eluted beyond P 4 in HPLC (Fig. 1, I -L) was investigated and illustrated here only for the embryo and the trilaminar trophoblast. In a second gradient system most of the radioactive material for the embryo was seen in association with the reference standard of 3b,5a-THP; lesser amounts of 5a-DHP were also detected (Fig. 4A) . In the isocratic system that followed there was much better separation of the reference standards, which allowed identification of 3b,5a-THP as the major metabolite and 5a-DHP as a minor product of 5a reduction (Fig. 4B) . Similar results were obtained with the more limited amounts of radioactive material available for the trophoblast, where 3b,5a-THP again was the major metabolite of 5a reduction; no 5a-DHP was detected (Fig. 4, C and D) . Competition from other enzyme activity is reflected in the formation of products from P 4 that are quantitatively significant but slightly more polar than the substrate (Fig. 4C) .
Incubations in the Presence of a 5a-Reductase Inhibitor (4-MA)
The 5a-reductase inhibitor (4-MA) showed clear suppression of 5a-reduced products from the D 4 3-oxo-steroid substrates T 4 and P 4 (Fig. 5) . In the case of T 4 metabolism both the embryo and the trophoblast failed to produce 3b,5a-THA and DHA in the presence of the inhibitor (Fig. 5, A and C) . Conversion of T 4 to A 4 by the 17b-hydroxysteroid dehydro- 
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genase (17b-HSD) remained active. An additional, very nonpolar peak of radioactivity was seen for the trophoblast; its formation was not suppressed by 4-MA, but increased by default (Fig. 5C, 39 min) . No further examination was done on this material. Similarly, inhibition of 5a-reduced products by 4-MA was observed when A 4 was the substrate for the embryo or trophoblast (data not shown). With P 4 metabolism it was also possible to demonstrate an inhibition of 5a reduction by 4-MA in the embryo and trophoblast (Fig. 5, B and D) ; the evidence was clear, particularly from the absence of the more prominent 5a-reduced product (''5a-THP'') eluted immediately after the substrate P 4 .
Absence of 5a-Reduced Products from D 5 3b-Hydroxysteroids
No evidence of 5-reductase activity was observed when D 5 3b-hydroxysteroids (pregnenolone, P 5 , and dehydroepiandrosterone) were used as substrates for the embryo proper (Fig. 6, A  and B) . Indeed, little steroid metabolism of any kind was evident; further chromatography in another solvent system revealed that about 10%-15% of P 5 had been converted to P 4 (data not shown). In contrast, extensive metabolism of P 5 to polar compounds was observed with the trophoblast (n ¼ 3, data not shown).
Competition from Sulfotransferase and Aromatase
All tissues showed formation of steroid conjugates except for the embryo proper with P 5 as substrate. Conjugation was low for the embryo with all three substrates (A 4 : 9.0% 6 3.7%, n ¼ 22; T 4 : 6.1% 6 2.2%, n ¼ 5; and P 4 : 10.3% 6 2.1%, n ¼ 8) but was much higher for the trophoblast, especially the trilaminar (56.4% 6 8.5%, n ¼ 21; 33.8% 6 10.8%, n ¼ 5; and 14.1% 6 5.2%, n ¼ 6, respectively). The amounts of radioactivity available for examination as free neutral steroids were reduced further when phenolic steroids were removed. The losses were negligible for the embryo with A 4 (7.3% 6 3.4%, n ¼ 24), for example, whereas the phenolic fractions were clearly significant for the bilaminar and trilaminar trophoblast (44.1% 6 13.0%, n ¼ 8; and 32.1% 6 8.5%, n ¼ 13, respectively). Furthermore, some radioactivity (15%-25%) was retained by the tissues; this material has not yet been examined.
DISCUSSION
The main objective of this investigation on neutral steroids in the early equine conceptus was to uncover the possible formation of 5-reduced steroids as metabolites that might have biological significance, especially at a paracrine/autocrine level. We have identified five 5a-reduced metabolites (DHA, 3b-THA, 3b-THT, DHP, and 3b-THP) as radiolabeled products from a series of chromatographic steps. An inhibitor of 5a-reductase activity (4-MA) was used to confirm that the metabolites were indeed present as 5a-reduced steroids.
Several features of early pregnancy peculiar to the mare have allowed these studies to be undertaken. For example, the nonsurgical collection of an intact conceptus and recovery of sufficient material from each of the different components of the conceptus would have been impracticable with most other species. This was especially true for the retrieval of an embryo proper at the earliest possible stage. How relevant the findings on steroid metabolism in the early equine conceptus are to early development in other mammalian species remains to be seen. However, the fact that mouse mES cells are capable of 
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secreting androgens, and thereby stimulate differentiation of mES cells to cardiomyocytes, sheds new light on the importance of steroid formation by the embryo in early development [10] . The mechanism of this action was recently shown to be through the classical AR-mediated genomic pathway [13] .
The revelation of extensive metabolism of neutral steroids in the equine conceptus extends our earlier findings for estrogens [14] . All substrates selected for the present study were C 19 and C 21 steroids known to be present in the yolk sac fluid of the equine conceptus [15] . The focus on 5a-reduced metabolites followed from our earlier observations that strongly suggested their formation from A 4 by the embryo proper [1] . A precedent for 5-reductase activity at early stages in mammalian embryo development exists in studies conducted on P 4 metabolism with blastocysts from rabbits, about 50 yr ago [8] . Two decades later, similar findings were made with morulae and blastocysts from hamsters [9] . In the rabbit the products were 5b-reduced steroids, whereas the hamster embryos formed mainly 5a-DHP, with lesser amounts of 3b,5a-THP. With regard to 5b-reduced steroids it may be noted that the 5b-DHT epimer was shown to be inactive in stimulating proliferative responses of normal rat ventral prostate [16] . No 5b-metabolites were identified in our work on the horse, as was the case for earlier studies with plasma of the mare, fetus, and newborn foal [17] .
The most striking finding in the present study was the extent to which 5a-metabolites of A 4 and T 4 were formed by the embryo proper, well before the stage of sexual differentiation and development [18] ; practically no other steroid products were seen. Interestingly, the major products from T 4 were the same as those from A 4 , presumably as a result of a predominant oxidative action of 17b-HSD. Thus, A 4 became the principal substrate for the 5a-reductase enzyme, and as a consequence no DHT was formed in the embryo at this early stage. However, the prominent position of DHT is well established in male sexual differentiation and virilization at fetal and postnatal stages in several species [19] . The question remained as to whether it might even be involved in the initiation of sexual differentiation. The formation of DHT from radioactive T 4 was investigated with embryos from the rabbit and rat, ranging from the sexually indifferent stages through the final phases of completion of sexual differentiation [20] . Conversion of T 4 to DHT occurred at the earliest stage examined; it appeared first in the urogenital sinus and urogenital tubercle and preceded both the onset of T 4 secretion by the fetal gonad and sexual differentiation of the tissues. In a similar study on T 4 metabolism during male sexual differentiation in the human embryo the formation of DHT was most rapid in tissues of the urogenital tract [21] . Production was maximal prior to the onset of male differentiation, suggesting that DHT is probably the effective intracellular androgen that mediates male development in these tissues. A key element for the appearance of DHT formation may well be the timing of the expression of a 17b-HSD to convert DHA to DHT. Indeed, the preferred pathway for DHT formation by the prostate gland in the mature human male is considered to be from DHA to DHT, rather than from T 4 to DHT [4, 22, 23] .
Because DHA and 3b,5a-THA rather than DHT were the major products of A 4 and T 4 metabolism in the early equine conceptus, what biological significance might these steroids   FIG. 4 . Identification of 5a-reduced metabolites formed by tissues from the conceptus with P 4 as substrate. Further resolution of the peak areas encompassing P 4 (fractions 37-42 min; Fig. 1I ) for the embryo and a greater range (fractions 31-42 min; Fig. 1L ) for the trophoblast was made with solvent system 2. For both tissues, 3b-THP was the major 5a-reduced product (A and C), with a small amount of DHP from the embryo. Identification of 3b,5a-THP and DHP was confirmed using the isocratic system 4 (B and D). Reference standards are numbered as follows: 7: P 4 ; 8: 3b,5a-THP; 9: 3a, 5a-THP; and 10: DHP.
have well before the onset of male differentiation? Not much information can be provided for DHA although 3b,5a-THA (epiandrosterone) has long been known as a weak androgen. With regard to the lesser amounts of 3b,5a-THT (androstanediol) identified in our work, it is interesting that this steroid is a specific agonist for the estrogen receptor b (ERb) [24] . The wide distribution of ERb revealed by immunohistochemistry in equine embryos [25] from other pregnancies in our studies suggests an involvement in early differentiation and organogenesis. The increasing production of estrogens by the trophoblast at this stage provides a more abundant supply of agonists for ERb, and yet the local production of androstanediol in an autocrine/paracrine manner may be suggested as a more immediate source of an agonist for the embryo proper.
Metabolism of P 4 in all components of the equine conceptuses was more complex than seen for the C 19 substrates and reflected the activity of enzymes in competition with 5a-reductase. Preliminary work did indicate that 3a/b-dihydro-P 4 and 20a/b-dihydro-P 4 could have been formed. With the 5a-reduced products being our immediate focus, we have not examined in depth any radioactive material that was more polar than P 4 . The further reduction of DHP to 3b,5a-THP was a major feature and could represent metabolism to a steroid that might favor cell differentiation as opposed to cell proliferation by DHP. To the best of our knowledge there are no reports on the biological actions of 3b,5a-THP. By contrast, the literature is extensive on 3a,5a-THP (allopregnanolone), for example, as a neuroactive metabolite of P 4 and a barbiturate-like modulator of central gamma-aminobutyric acid receptors that modify a range of behaviors. [26] .
It would be difficult for many reasons to replicate in the horse what has been achieved in the other species with regard to an investigation of 5a-reductase activity in specific tissues. The formation of DHT from T 4 has been demonstrated in many tissues of the human embryo, albeit at much lower levels than in the urogenital tissues [22] . Detection of 5a-reduction in 
other tissues of the equine embryo is of interest, but metabolic studies using radioactive steroids for individual organs at the stage of embryo development seen in our present report would be impracticable. However, preliminary studies using immunohistochemistry have shown promise as a means for investigation of tissues that express 5a-reductases at this early stage, and they are now being identified (M.A. Hayes, private communication).
In summary, our study has revealed a remarkable degree of 5a-reductase activity in the metabolism of neutral C 21 and C 19 steroids by the early equine conceptus. We have identified five 5a-reduced products (DHA; 3b,5a-THA; 3b,5a-THT; DHP; and 3b,5a-THP) as the most prominent feature for the embryo proper (Fig. 7) . In view of the known biological effects of some of these metabolites in fetal and postnatal stages, additional studies are required to determine whether there is a role for such local metabolism in the early development of the equine conceptus. Investigation of the possible presence of 5a-reductase activity and its potential significance more generally in the embryogenesis of other mammalian species is suggested.
